Osteonic오스테오닉
226400 · KOSDAQ · ₩226400 · 오스테오닉
- Market cap
- ₩88B
- Enterprise value
- ₩98B
- P/E
- 8.7×
- P/B
- 1.2×
- Dividend yield
- 0.0%
- ROE
- 14.2%
- Net margin
- 20.0%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−44.8% from the high
₩3,710Today: ₩4,150 – ₩4,300₩7,720
Returns
- 1W+0.7%
- 1M+7.0%
- 3M−8.1%
- 6M−37.7%
- YTD−31.5%
- 1Y−44.2%
- Volume today
- 57,599
- 0.6× the 20-day average
- Traded today
- ₩244M
- Listed shares
- 20,768,101
- EPS (12 months)
- ₩491
- Earnings yield 11.5%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 36 of 100 (50 is a normal day for this stock).
- MomentumFlat3.1% over the last month; the price is above its 20-day average.
- News impactLow1 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
Osteonic stock overview
Osteonic (오스테오닉, KRX: 226400) is listed on KOSDAQ, in the Medical & precision devices sector. The company designs and sells medical devices, mainly implants used to fix, replace, and adjust most bones of the human body except the spine and hip. Its shares closed at ₩4,260 on Oct 27, 2026, up 2.04% on the day, giving it a market value of ₩88B.
Key facts
- Market cap
- ₩88B
- Sector
- Medical & precision devices
- Latest price change
- +2.04%
- As of
- Oct 27, 2026
- Main business
- The company designs and sells medical devices, mainly implants used to fix, replace, and adjust most bones of the human body except the spine and hip.
Quick answers about Osteonic
- What does Osteonic do?
- The company designs and sells medical devices, mainly implants used to fix, replace, and adjust most bones of the human body except the spine and hip. Its products are made from metals such as titanium and stainless steel or from bio-materials such as PEEK and biocomposites. Its main product lines cover craniomaxillofacial, trauma and extremities, sports medicine (joint preservation), and spine implants, with sports medicine and trauma products accounting for the largest shares of its sales.
- What is the market cap of Osteonic?
- The market capitalisation of Osteonic was ₩88B at the close on Oct 27, 2026.
- Who are the largest shareholders of Osteonic?
- According to the latest official filings, the largest reported holders are Lee Dong-won (21.20%, as of Sep 4, 2026); GV A Asset Management (5.00%, as of Jun 8, 2026); Fine Value Asset Management (4.90%, as of Feb 27, 2025).
- When is the next earnings report from Osteonic?
- Korean companies rarely announce results dates in advance. Based on when Osteonic filed the same report in past years, its next 3q results is expected between Nov 12, 2026 and Nov 14, 2026.
- Does the National Pension Service own Osteonic?
- Yes. The National Pension Service held 0.30% of Osteonic shares as of Dec 31, 2025.
Company profile
The company designs and sells medical devices, mainly implants used to fix, replace, and adjust most bones of the human body except the spine and hip. Its products are made from metals such as titanium and stainless steel or from bio-materials such as PEEK and biocomposites. Its main product lines cover craniomaxillofacial, trauma and extremities, sports medicine (joint preservation), and spine implants, with sports medicine and trauma products accounting for the largest shares of its sales.
Written by AI from the company's latest annual report.
- Korean name
- 오스테오닉
- Themes
- Medical devices
- CEO
- 이동원
- Founded
- Mar 2012
- Listed
- Feb 2018
- Listed shares
- 20,768,101
- Fiscal year ends
- Month 12
- Website
- www.osteonic.com
Similar companies
- TSE131290 · ₩2.9T₩260,000+7.88%
- Kctech281820 · ₩1.8T₩91,900+6.37%
- Classys214150 · ₩1.7T₩26,500−2.57%
- Park Systems140860 · ₩1.6T₩225,500+1.12%
- Curiox Biosystems445680 · ₩1.1T₩62,300+6.13%
- DI003160 · ₩1.1T₩37,800+4.71%
- Seers458870 · ₩1T₩26,300−5.57%
- LivsMed491000 · ₩937B₩37,100+1.50%
Recent filings
See all- Decision on Increase in Short-Term BorrowingsOct 22, 2026
- Amended: Half-year report (Jun 2026)Sep 29, 2026
- 5%+ holding reportSep 4, 2026
- Added attachment: Half-year report (Jun 2026)Aug 14, 2026
- 5%+ holding reportAug 3, 2026
Titles in Korean until English translations are added.
Also known as: Osteonic / 오스테오닉 / 226400 / KRX:226400
Source: KRX statistical information